Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) FCF Margin (2016 - 2025)

Historic FCF Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 430.85%.

  • Ocular Therapeutix's FCF Margin fell 1988500.0% to 430.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 417.5%, marking a year-over-year decrease of 2041200.0%. This contributed to the annual value of 417.5% for FY2025, which is 2041300.0% down from last year.
  • Ocular Therapeutix's FCF Margin amounted to 430.85% in Q4 2025, which was down 1988500.0% from 389.98% recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's FCF Margin registered a high of 52.99% during Q3 2023, and its lowest value of 435.63% during Q1 2025.
  • For the 5-year period, Ocular Therapeutix's FCF Margin averaged around 209.82%, with its median value being 163.53% (2023).
  • Per our database at Business Quant, Ocular Therapeutix's FCF Margin skyrocketed by 7787300bps in 2021 and then tumbled by -2651300bps in 2025.
  • Ocular Therapeutix's FCF Margin (Quarter) stood at 128.24% in 2021, then fell by -6bps to 135.76% in 2022, then dropped by -14bps to 154.81% in 2023, then plummeted by -50bps to 232.0% in 2024, then tumbled by -86bps to 430.85% in 2025.
  • Its last three reported values are 430.85% in Q4 2025, 389.98% for Q3 2025, and 419.67% during Q2 2025.